EZH2 and lung carcinoma: We explored whether FAK inhibition induces cellular senescence through an EZH2 inhibition-mediated pathway by treating lung cancer cells with a FAK inhibitor, PF-573228, and examining whether FAK inhibition affects EZH2 expression or function.